• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多培沙明或多巴酚丁胺治疗的内毒素血症大鼠的器官血流及心输出量分布

Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats.

作者信息

van Lambalgen A A, van Kraats A A, Mulder M F, van den Bos G C, Teerlink T, Thijs L G

机构信息

Laboratory for Physiology, Free University, Amsterdam, The Netherlands.

出版信息

J Crit Care. 1993 Jun;8(2):117-27. doi: 10.1016/0883-9441(93)90016-e.

DOI:10.1016/0883-9441(93)90016-e
PMID:8102078
Abstract

Endotoxemia causes a decrease of blood flow to most organs. If this could be prevented, chances of survival might improve. In endotoxemic rats, we studied the effect of a therapeutic infusion of dopexamine (dopaminergic, beta 2-adrenergic) on blood flow and percentage of the cardiac output distributed to heart, brain, hepatic artery, stomach, intestines, spleen, pancreas, kidneys, adrenals, diaphragm, skeletal muscle, and skin. Dopexamine action was compared with that of dobutamine (beta 1-adrenergic). Endotoxin shock was induced in 28 rats with infusion of 8 mg/kg Escherichia coli O127:B8 endotoxin from 0 to 60 minutes; the rats were then divided into 3 groups, which received from 60 to 135 minutes of an infusion of saline (ES; n = 10), dopexamine hydrochloride (DX, 3 x 10(-8) mol/kg.min; n = 10) or dobutamine (DB, 10(-7) mol/kg.min; n = 8). A fourth group served as time-matched controls (C, saline from 0 to 135 minutes; n = 8). In the untreated endotexemic rats, cardiac output decreased and organ blood flow decreased except in the diaphragm, heart, and brain; the percentage of the cardiac output to those organs increased. Dopexamine and dobutamine similarly improved cardiac output in endotoxemic rats. All organs benefitted to the same extent from the increased cardiac output. Therapeutic infusion of dopexamine during endotoxemia did not favor flow to any particular organ; redistribution of cardiac output changed little after administration of dopexamine, and its effects were not significantly different from those of dobutamine.

摘要

内毒素血症会导致多数器官的血流减少。如果能够预防这种情况,存活几率可能会提高。在患有内毒素血症的大鼠中,我们研究了治疗性输注多培沙明(多巴胺能、β2肾上腺素能)对血流以及分配至心脏、脑、肝动脉、胃、肠、脾、胰腺、肾、肾上腺、膈肌、骨骼肌和皮肤的心输出量百分比的影响。将多培沙明的作用与多巴酚丁胺(β1肾上腺素能)的作用进行了比较。给28只大鼠在0至60分钟内输注8mg/kg大肠杆菌O127:B8内毒素以诱导内毒素休克;然后将大鼠分为3组,在60至135分钟内分别接受生理盐水输注(ES;n = 10)、盐酸多培沙明(DX,3×10⁻⁸mol/kg·min;n = 10)或多巴酚丁胺(DB,10⁻⁷mol/kg·min;n = 8)。第四组作为时间匹配的对照组(C,在0至135分钟内输注生理盐水;n = 8)。在未经治疗的内毒素血症大鼠中,心输出量下降,除膈肌、心脏和脑外的器官血流减少;这些器官的心输出量百分比增加。多培沙明和多巴酚丁胺同样改善了内毒素血症大鼠的心输出量。所有器官从增加的心输出量中受益程度相同。在内毒素血症期间治疗性输注多培沙明对任何特定器官的血流均无促进作用;多培沙明给药后心输出量的重新分配变化不大,其效果与多巴酚丁胺的效果无显著差异。

相似文献

1
Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats.多培沙明或多巴酚丁胺治疗的内毒素血症大鼠的器官血流及心输出量分布
J Crit Care. 1993 Jun;8(2):117-27. doi: 10.1016/0883-9441(93)90016-e.
2
Effects of dobutamine and dopexamine on hepatic micro- and macrocirculation during experimental endotoxemia: an intravital microscopic study in the rat.多巴酚丁胺和多培沙明对实验性内毒素血症期间肝脏微循环和大循环的影响:大鼠活体显微镜研究
Crit Care Med. 2001 Mar;29(3):597-600. doi: 10.1097/00003246-200103000-00023.
3
High-energy phosphates in heart, liver, kidney, and skeletal muscle of endotoxemic rats.内毒素血症大鼠心脏、肝脏、肾脏和骨骼肌中的高能磷酸酯
Am J Physiol. 1994 Apr;266(4 Pt 2):H1581-7. doi: 10.1152/ajpheart.1994.266.4.H1581.
4
[Dopexamine: a new dopaminergic agonist].多培沙明:一种新型多巴胺能激动剂
Ann Fr Anesth Reanim. 1993;12(3):308-20. doi: 10.1016/s0750-7658(05)80658-6.
5
Goal-directed therapy with dopexamine, dobutamine, and volume expansion: effects of systemic oxygen transport on hepatic ultrastructure in porcine sepsis.
Crit Care Med. 1995 Dec;23(12):1997-2007. doi: 10.1097/00003246-199512000-00008.
6
Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.去甲肾上腺素治疗的感染性休克中多巴酚丁胺和多培沙明的全身和局部效应比较
Intensive Care Med. 1999 Sep;25(9):942-8. doi: 10.1007/s001340050986.
7
Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.实验性内毒素血症休克期间的正性肌力支持:第二部分。左西孟旦与多巴酚丁胺的比较。
Anesth Analg. 2009 Nov;109(5):1576-83. doi: 10.1213/ane.0b013e3181af40e0. Epub 2009 Aug 27.
8
The fall of cardiac output in endotoxemic rats cannot explain all changes in organ blood flow: a comparison between endotoxin and low venous return shock.内毒素血症大鼠心输出量的下降并不能解释器官血流的所有变化:内毒素与低静脉回流性休克的比较。
Shock. 1996 Feb;5(2):135-40. doi: 10.1097/00024382-199602000-00009.
9
Effects of dopamine, dopexamine and dobutamine on renal excretory function during experimental sepsis in conscious rats.
Acta Anaesthesiol Scand. 1997 Mar;41(3):392-8. doi: 10.1111/j.1399-6576.1997.tb04705.x.
10
Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs.
Am J Cardiol. 1988 Aug 11;62(5):30C-36C. doi: 10.1016/s0002-9149(88)80064-x.

引用本文的文献

1
Renal blood flow in sepsis.脓毒症中的肾血流量。
Crit Care. 2005 Aug;9(4):R363-74. doi: 10.1186/cc3540. Epub 2005 May 24.
2
Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.大鼠中β-肾上腺素能激动剂的抗抑郁样行为效应与环磷酸腺苷磷酸二酯酶抑制剂咯利普兰之间的相互作用。
Psychopharmacology (Berl). 2005 Oct;182(1):104-15. doi: 10.1007/s00213-005-0055-y. Epub 2005 Sep 29.
3
Cannabinoid antagonist SR-141716 inhibits endotoxic hypotension by a cardiac mechanism not involving CB1 or CB2 receptors.
大麻素拮抗剂SR-141716通过一种不涉及CB1或CB2受体的心脏机制抑制内毒素性低血压。
Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H595-600. doi: 10.1152/ajpheart.00184.2004. Epub 2004 Apr 1.
4
Selective versus non-selective suppression of nitric oxide synthase on regional hemodynamics in rats with or without LPS-induced endotoxemia.选择性与非选择性抑制一氧化氮合酶对伴有或不伴有脂多糖诱导内毒素血症大鼠局部血流动力学的影响
Naunyn Schmiedebergs Arch Pharmacol. 2003 Apr;367(4):372-9. doi: 10.1007/s00210-002-0684-1. Epub 2003 Mar 4.